tiprankstipranks
Advertisement
Advertisement
Zimmer Biomet Kept at Hold as Analyst Awaits Proof of Salesforce Overhaul, Margin Stability and Robotics‑Driven Upside
PremiumRatingsZimmer Biomet Kept at Hold as Analyst Awaits Proof of Salesforce Overhaul, Margin Stability and Robotics‑Driven Upside
25d ago
BMO starts Zimmer at Market Perform, says valuation appears attractive
Premium
The Fly
BMO starts Zimmer at Market Perform, says valuation appears attractive
25d ago
Zimmer Biomet initiated with a Market Perform at BMO Capital
Premium
The Fly
Zimmer Biomet initiated with a Market Perform at BMO Capital
25d ago
The Week That Was, The Week Ahead: Macro and Markets, June 21
PremiumMarket NewsThe Week That Was, The Week Ahead: Macro and Markets, June 21
1M ago
Zimmer Biomet’s Sidus Stem-Free Shoulder Study Update: What Investors Should Know
Premium
Company Announcements
Zimmer Biomet’s Sidus Stem-Free Shoulder Study Update: What Investors Should Know
2M ago
Zimmer Biomet price target lowered to $93 from $95 at Citi
Premium
The Fly
Zimmer Biomet price target lowered to $93 from $95 at Citi
2M ago
Zimmer Biomet price target lowered to $92 from $98 at Truist
PremiumThe FlyZimmer Biomet price target lowered to $92 from $98 at Truist
3M ago
Zimmer Biomet participates in a conference call with JPMorgan
Premium
The Fly
Zimmer Biomet participates in a conference call with JPMorgan
3M ago
Zimmer Biomet: Hold Reiterated as Execution Risks, Salesforce Transition, and CFO Departure Offset Q1 Beat and Margin Upside
Premium
Ratings
Zimmer Biomet: Hold Reiterated as Execution Risks, Salesforce Transition, and CFO Departure Offset Q1 Beat and Margin Upside
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100